knowledge -WSS

knowledge

author：focus 2025-09-07 11:16:34 - browse：29

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： What the airline industry can learn from medicine

explore

WSS

Mega Millions pot grows to $1.25 billion after no winner

What to watch for from Zogenix and Amicus clinical trials

No plane should take off without an EpiPen onboard

Trump indictment: Who are the 'co

No plane should take off without an EpiPen onboard

Mitch McConnell episode has important public health takeaway

hotspot

knowledge

explore

Medical leaders decry Supreme Court decision on affirmative action

‘Oppenheimer’ and the risks of AI in health care

Novavax promises a turnaround & Lilly roils the obesity market

Biden warns of ‘dark winter’ during final presidental debate

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Report: Patient voices and perspectives

United colonoscopy coverage change 'may cost lives,' doctors say

Biogen says it will cut costs by $700 million, slash 1,000 jobs

As demand for Covid shots wanes, Moderna seeks its next success

Dems pitch expanding Medicare power to negotiate drug prices

knowledge

Trump indictment: Who are the 'co

New lawsuit accuses health insurer Cigna of denying claims in bulk

Scientists inch closer to single

Roche’s Alnylam deal shows drug firms interested in heart drugs

What it's like to live with paralysis for one psychologist

Vertex non

entertainment

explore

hotspot

knowledge